PREVENTION OF CYTOKINE-INDUCED CHANGES IN LEUKOCYTE ADHESION RECEPTORS BY NONSTEROIDAL ANTIINFLAMMATORY DRUGS FROM THE OXICAM FAMILY

Citation
R. Garciavicuna et al., PREVENTION OF CYTOKINE-INDUCED CHANGES IN LEUKOCYTE ADHESION RECEPTORS BY NONSTEROIDAL ANTIINFLAMMATORY DRUGS FROM THE OXICAM FAMILY, Arthritis and rheumatism, 40(1), 1997, pp. 143-153
Citations number
50
Categorie Soggetti
Rheumatology
Journal title
ISSN journal
00043591
Volume
40
Issue
1
Year of publication
1997
Pages
143 - 153
Database
ISI
SICI code
0004-3591(1997)40:1<143:POCCIL>2.0.ZU;2-V
Abstract
Objective. To explore the effect of the nonsteroidal antiinflammatory drugs (NSAIDs) piroxicam and meloxicam on quantitative and qualitative changes in leukocyte adhesion receptors induced by cytokines and othe r activation stimuli. Methods. The expression of CD11b and L-selectin during neutrophil activation with tumor necrosis factor alpha (TNF alp ha), granulocyte-macrophage colony-stimulating factor (GM-CSF), FMLP, phorbol myristate acetate (PMA), and calcium ionophore A23187 was asse ssed by flow cytometry. Enzyme-linked immunosorbent assays were used t o quantitate soluble L-selectin shed after neutrophil stimulation. Enz yme release was measured to determine neutrophil degranulation by proi nflammatory stimuli. Changes in affinity state of beta 1 and beta 2 in tegrins after neutrophil and T lymphocyte stimulation were assessed, b y flow cytometry, using the monoclonal antibodies (MAb) HUTS-21 (anti- beta 1) and CBRM1/5 (anti-CD11b), which recognize activation-dependent epitopes on these two integrins. Results. Pretreatment of neutrophils with either NSAID prevented the changes in L-selectin and CD11b expre ssion induced by TNF alpha, GM-CSF, and FMLP, but not those induced by PMA or A23187. Furthermore, piroxicam significantly decreased the amo unt of L-selectin shed by cytokine-treated neutrophils, whereas it did not exert this effect on PMA- or A23187-treated neutrophils. Piroxica m also decreased the release of gelatinase and lysozyme induced by TNF alpha, but not by PMA. Interestingly, piroxicam prevented the conform ational changes that beta 2 integrins underwent upon activation of neu trophils: the appearance of the activation epitope of CD11b, detected by the CBRM1/5 MAb, was blocked by piroxicam in TNF alpha-treated neut rophils. Moreover, in chemokine-treated T lymphocytes, the expression of activation epitopes on beta 1 integrins was also diminished by piro xicam. In contrast, this NSAID did not affect the beta 1 integrin conf ormational changes induced by PMA or Mn++. Conclusion. Our results ind icate that members of the oxicam family are able to interfere with eve nts of neutrophil function, such as their degranulation and cytokine-m ediated activation changes in adhesion molecules, both in neutrophils and in lymphocytes. Such effects may significantly contribute to the a ntiinflammatory activity of these drugs.